Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | CCND2 |
| Upstream (Parents) |
|---|
| (<<) ZNF711 → CCND2 |
| (<<) ADRA1B → CCND2 |
| (<<) SLC25A36 → CCND2 |
| (<<) STK38L → CCND2 |
| (<<) CD9 → CCND2 |
| Downstream (Children) |
|---|
| CCND2 → DEFA5 (>>) |
| CCND2 → CXXC4 (>>) |
| CCND2 → GRM5 (>>) |
| CCND2 → ABO (>>) |
| CCND2 → DPPA4 (>>) |
| CCND2 → PCSK1N (>>) |
| CCND2 → CG030 (>>) |
| CCND2 → NAT8B (>>) |
| CCND2 → GPC1 (>>) |
| CCND2 → TMSB15B///TMSB15A (>>) |
